Literature DB >> 33587003

Damage-Associated Molecular Patterns As Double-Edged Swords in Sepsis.

Mian Zhou1, Monowar Aziz1, Ping Wang1,2.   

Abstract

Significance: Sepsis is defined as a life-threatening organ dysfunction caused by dysregulated host response to infection. This leads to an uncontrolled inflammatory response at the onset of infection, followed by immunosuppression. The development of a specific treatment modality for sepsis is still challenging, reflecting our inadequate understanding of its pathophysiology. Understanding the mechanism and transition of the early hyperinflammation to late stage of immunosuppression in sepsis is critical for developing sepsis therapeutics. Recent Advances: Damage-associated molecular patterns (DAMPs) are intracellular molecules and released upon tissue injury and cell death in sepsis. DAMPs are recognized by pattern recognition receptors to initiate inflammatory cascades. DAMPs not only elicit an inflammatory response but also they subsequently induce immunosuppression, both are equally important for exacerbating sepsis. Recent advances on a new DAMP, extracellular cold-inducible RNA-binding protein for fueling inflammation and immunosuppression in sepsis, have added a new avenue into the dual functions of DAMPs in sepsis. Critical Issues: The molecular modification of DAMPs and their binding to pattern recognition receptors transit dynamically by the cellular environment in pathophysiologic conditions. Correlation between the dynamic changes of the impacts of DAMPs and the clinical outcomes in sepsis still lacks adequate understanding. Here, we focus on the impacts of DAMPs that cause inflammation as well as induce immunosuppression in sepsis. We further discuss the therapeutic potential by targeting DAMPs to attenuate inflammation and immunosuppression for mitigating sepsis. Future Directions: Uncovering pathways of the transition from inflammation to immunosuppression of DAMPs is a potential therapeutic avenue for mitigating sepsis.

Entities:  

Keywords:  ATP; DAMP; HMGB1; eCIRP; histones; immunosuppression; inflammation

Mesh:

Year:  2021        PMID: 33587003      PMCID: PMC8817718          DOI: 10.1089/ars.2021.0008

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  145 in total

1.  "Host tissue damage" signal ATP promotes non-directional migration and negatively regulates toll-like receptor signaling in human monocytes.

Authors:  Andreas Kaufmann; Boris Musset; Sven H Limberg; Vijay Renigunta; Rainer Sus; Alexander H Dalpke; Klaus M Heeg; Bernard Robaye; Peter J Hanley
Journal:  J Biol Chem       Date:  2005-07-19       Impact factor: 5.157

2.  Septic shock--evaluating another failed treatment.

Authors:  Richard P Wenzel; Michael B Edmond
Journal:  N Engl J Med       Date:  2012-05-22       Impact factor: 91.245

Review 3.  Extracellular ATP and adenosine: The Yin and Yang in immune responses?

Authors:  M M Faas; T Sáez; P de Vos
Journal:  Mol Aspects Med       Date:  2017-01-16

4.  HMGB1 mediates cognitive impairment in sepsis survivors.

Authors:  Sangeeta S Chavan; Patricio T Huerta; Sergio Robbiati; S I Valdes-Ferrer; Mahendar Ochani; Meghan Dancho; Maya Frankfurt; Bruce T Volpe; Kevin J Tracey; Betty Diamond
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

Review 5.  Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

Authors:  K J Tracey; A Cerami
Journal:  Annu Rev Med       Date:  1994       Impact factor: 13.739

6.  Cold-inducible RNA-binding protein modulates circadian gene expression posttranscriptionally.

Authors:  Jörg Morf; Guillaume Rey; Kim Schneider; Markus Stratmann; Jun Fujita; Felix Naef; Ueli Schibler
Journal:  Science       Date:  2012-08-23       Impact factor: 47.728

7.  Increased Plasma Levels of Danger-Associated Molecular Patterns Are Associated With Immune Suppression and Postoperative Infections in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Guus P Leijte; Hettie Custers; Jelle Gerretsen; Amon Heijne; Johannes Roth; Thomas Vogl; Gert J Scheffer; Peter Pickkers; Matthijs Kox
Journal:  Front Immunol       Date:  2018-04-05       Impact factor: 7.561

8.  Targeting the eCIRP/TREM-1 interaction with a small molecule inhibitor improves cardiac dysfunction in neonatal sepsis.

Authors:  Naomi-Liza Denning; Monowar Aziz; Li Diao; Jose M Prince; Ping Wang
Journal:  Mol Med       Date:  2020-12-04       Impact factor: 6.354

Review 9.  Biology, role and therapeutic potential of circulating histones in acute inflammatory disorders.

Authors:  Peter Szatmary; Wei Huang; David Criddle; Alexei Tepikin; Robert Sutton
Journal:  J Cell Mol Med       Date:  2018-08-07       Impact factor: 5.310

Review 10.  Targeting Inflammation Driven by HMGB1.

Authors:  Huan Yang; Haichao Wang; Ulf Andersson
Journal:  Front Immunol       Date:  2020-03-20       Impact factor: 7.561

View more
  5 in total

Review 1.  High Mobility Group Proteins in Sepsis.

Authors:  Guibin Liang; Zhihui He
Journal:  Front Immunol       Date:  2022-06-02       Impact factor: 8.786

Review 2.  Systemic inflammatory response syndrome is triggered by mitochondrial damage (Review).

Authors:  Can Kong; Wei Song; Tao Fu
Journal:  Mol Med Rep       Date:  2022-03-02       Impact factor: 2.952

Review 3.  Chromatin-Associated Molecular Patterns (CAMPs) in sepsis.

Authors:  Ping Wang; Monowar Aziz; Colleen P Nofi
Journal:  Cell Death Dis       Date:  2022-08-12       Impact factor: 9.685

4.  A microsatellite DNA-derived oligodeoxynucleotide attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting the HMGB1-TLR4-NF-κB signaling pathway.

Authors:  Chenghua Zhang; Hui Wang; Hongrui Wang; Shuyou Shi; Peiyan Zhao; Yingying Su; Hua Wang; Ming Yang; Mingli Fang
Journal:  Front Microbiol       Date:  2022-08-04       Impact factor: 6.064

Review 5.  Role of DAMPs in respiratory virus-induced acute respiratory distress syndrome-with a preliminary reference to SARS-CoV-2 pneumonia.

Authors:  Walter Gottlieb Land
Journal:  Genes Immun       Date:  2021-06-17       Impact factor: 2.676

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.